ProfileGDS4718 / 1561106_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 13% 22% 12% 16% 18% 12% 14% 20% 21% 21% 16% 19% 13% 10% 12% 18% 20% 9% 13% 11% 19% 17% 15% 11% 16% 20% 13% 14% 21% 12% 17% 13% 11% 20% 11% 13% 9% 15% 18% 14% 11% 13% 10% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9189113
GSM549102patient 115, normal, homogenized [OPG study]4.2506122
GSM549104patient 119, normal, homogenized [OPG study]3.8142912
GSM549108patient 138, normal, homogenized [OPG study]4.0384516
GSM549119patient 077, normal, homogenized [OPG study]4.0813618
GSM549133patient 032, cancer, homogenized [OPG study]3.8158312
GSM549139patient 042, cancer, homogenized [OPG study]3.8932214
GSM549099patient 107, normal, homogenized [OPG study]4.1783320
GSM549109patient 139, normal, homogenized [OPG study]4.2133121
GSM549110patient 046, normal, homogenized [OPG study]4.1888621
GSM549114patient 063, normal, homogenized [OPG study]3.9811316
GSM549122patient 082, normal, homogenized [OPG study]4.1065219
GSM549134patient 033, cancer, homogenized [OPG study]3.8977413
GSM549136patient 036, cancer, homogenized [OPG study]3.7292410
GSM549140patient 044, cancer, homogenized [OPG study]3.8335812
GSM549111patient 047, normal, homogenized [OPG study]4.0462818
GSM549113patient 057, normal, homogenized [OPG study]4.1105420
GSM549132patient 031, cancer, homogenized [OPG study]3.730619
GSM549137patient 038, cancer, homogenized [OPG study]3.8806913
GSM549142patient 047, cancer, homogenized [OPG study]3.8684611
GSM549100patient 110, normal, homogenized [OPG study]4.1216619
GSM549107patient 135, normal, homogenized [OPG study]4.0200717
GSM549115patient 068, normal, homogenized [OPG study]3.9334415
GSM549116patient 072, normal, homogenized [OPG study]3.8088911
GSM549120patient 078, normal, homogenized [OPG study]3.9882116
GSM549131patient 030, cancer, homogenized [OPG study]4.0824620
GSM549118patient 074, normal, homogenized [OPG study]3.9062613
GSM549129patient 027, cancer, homogenized [OPG study]3.933914
GSM549123patient 088, normal, homogenized [OPG study]4.1592421
GSM549124patient 006, cancer, homogenized [OPG study]3.8890812
GSM549126patient 015, cancer, homogenized [OPG study]4.0384517
GSM549128patient 025, cancer, homogenized [OPG study]3.881813
GSM549103patient 117, normal, homogenized [OPG study]3.8602911
GSM549117patient 073, normal, homogenized [OPG study]4.1486620
GSM549138patient 041, cancer, homogenized [OPG study]3.785911
GSM549141patient 045, cancer, homogenized [OPG study]3.8345313
GSM549130patient 028, cancer, homogenized [OPG study]3.754329
GSM549101patient 111, normal, homogenized [OPG study]3.9814715
GSM549105patient 128, normal, homogenized [OPG study]4.0645318
GSM549106patient 134, normal, homogenized [OPG study]3.875414
GSM549112patient 048, normal, homogenized [OPG study]3.8088911
GSM549125patient 011, cancer, homogenized [OPG study]3.9100813
GSM549127patient 024, cancer, homogenized [OPG study]3.7528410
GSM549135patient 035, cancer, homogenized [OPG study]3.8421513